Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-639.84%
operating margin TTM
-719.97%
revenue TTM
28.54 Million
revenue per share TTM
0.48$
valuation ratios | |
|---|---|
| pe ratio | -3.87 |
| peg ratio | 0.02 |
| price to book ratio | 1.47 |
| price to sales ratio | 25.02 |
| enterprise value multiple | -3.68 |
| price fair value | 1.47 |
profitability ratios | |
|---|---|
| gross profit margin | 82.07% |
| operating profit margin | -719.97% |
| pretax profit margin | -641.38% |
| net profit margin | -639.84% |
| return on assets | -35.66% |
| return on equity | -34.11% |
| return on capital employed | -42.23% |
liquidity ratios | |
|---|---|
| current ratio | 14.19 |
| quick ratio | 13.59 |
| cash ratio | 1.93 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 1,081.56 |
| operating cycle | 1,170.71 |
| days of payables outstanding | 423.75 |
| cash conversion cycle | 746.96 |
| receivables turnover | 4.09 |
| payables turnover | 0.86 |
| inventory turnover | 0.34 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | 0.03 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.03 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -10.64 |
cash flow ratios | |
|---|---|
| free cash flow per share | -6.54 |
| cash per share | 12.54 |
| operating cash flow per share | -6.47 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -10.64 |
| short term coverage ratios | -20.23 |
| capital expenditure coverage ratio | -88.08 |
Frequently Asked Questions
When was the last time Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) reported earnings?
Agios Pharmaceuticals, Inc. (AGIO) published its most recent earnings results on 29-04-2026.
What is Agios Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)'s trailing twelve months ROE is -34.11%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Agios Pharmaceuticals, Inc. (AGIO) currently has a ROA of -35.66%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AGIO's net profit margin stand at?
AGIO reported a profit margin of -639.84% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AGIO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 14.19 in the most recent quarter. The quick ratio stood at 13.59, with a Debt/Eq ratio of 0.03.